Cargando…
Discovery of N-phenyl-(2,4-dihydroxypyrimidine-5-sulfonamido) phenylurea-based thymidylate synthase (TS) inhibitor as a novel multi-effects antitumor drugs with minimal toxicity
Thymidylate synthase (TS) is a hot target for tumor chemotherapy, and its inhibitors are an essential direction for anti-tumor drug research. To our knowledge, currently, there are no reported thymidylate synthase inhibitors that could inhibit cancer cell migration. Therefore, for optimal therapeuti...
Autores principales: | Li, Xin-yang, Zhang, Ting-jian, Kamara, Mohamed Olounfeh, Lu, Guo-qing, Xu, Hai-li, Wang, De-pu, Meng, Fan-hao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6624297/ https://www.ncbi.nlm.nih.gov/pubmed/31296849 http://dx.doi.org/10.1038/s41419-019-1773-0 |
Ejemplares similares
-
N-Benzoyl-N′-phenylurea
por: Okuniewski, Andrzej, et al.
Publicado: (2010) -
Development of a novel thymidylate synthase (TS) inhibitor capable of up-regulating P53 expression and inhibiting angiogenesis in NSCLC
por: Li, Xin-yang, et al.
Publicado: (2020) -
Targeting Methyltransferases in Human Pathogenic Bacteria: Insights into Thymidylate Synthase (TS) and Flavin-Dependent TS (FDTS)
por: Pozzi, Cecilia, et al.
Publicado: (2019) -
The ability to accumulate deoxyuridine triphosphate and cellular response to thymidylate synthase (TS) inhibition
por: Webley, S D, et al.
Publicado: (2001) -
Changes in the status of p53 affect drug sensitivity to thymidylate synthase (TS) inhibitors by altering TS levels
por: Giovannetti, E, et al.
Publicado: (2007)